Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘OptumLabs’

March 22, 2021 · Leave a Comment

Mayo Clinic Research in the news — 3/22/2021

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

News including Mayo Clinic research and research expertise this week covered a wide range of topics, including genetic testing to inform prescribing blood thinners and therapies for bile duct and gall bladder cancers. A number of women’s health related articles highlighted Mayo Clinic research, there were some arguments for naps, and the ever present COVID-19 […]

View full entry Comment on this

Tags: antiplatelet, asthma, bile duct cancer, breast cancer, COVID-19, Diego Zaquera Carvalho, Elizabeth Stewart, gall bladder cancer, gastroenterology, genetic testing, genetics, genomics


February 8, 2021 · Leave a Comment

Mayo Clinic Research in the news — 2/8/2021

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

In the week’s news, you can find expertise from Mayo Clinic clinicians and researchers on a range of topics, including several different heart conditions, a blood test for Alzheimer’s, cancer, disparities in diabetes care, and of course COVID-19. Expertise from a Mayo Clinic International consultant is also highlighted, along with Michael Camilleri, M.D., who received […]

View full entry Comment on this

Tags: Alzheimer's disease, artificial intelligence, Bart Demaerschalk, blood cancer, blood disease, blood test, breast cancer, cardiology, cardiovascular disease, caregivers, Center for Digital Health, Center for the Science of Health Care Delivery


February 2, 2021 · Leave a Comment

Diabetes treatment disparities widespread, room for improvement

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

More than 34 million people in the U.S. have diabetes, reports the Centers for Disease Control and Prevention. Of these, the vast majority have type 2, or a reduced ability of their bodies to effectively process sugar in foods into energy for life. Most people with type 2 diabetes have multiple considerations – including heart […]

View full entry Comment on this

Tags: Centers for Disease Control and Prevention, diabetes, health care value, health disparities, health equity, heart disease, hypoglycemia, kidney disease, medication management, OptumLabs, pharmacy, Rozalina McCoy


March 3, 2020 · Leave a Comment

Research News Roundup–February 2020

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

Each month, we publish Mayo Clinic’s Research News Roundup. This article includes brief summaries and links to news releases from the preceding month that discuss some of our latest medical research and/or research education. It also connects readers to related resources. Read on for recent findings of Mayo Clinic Research: Florida State University and Mayo Clinic […]

View full entry Comment on this

Tags: Amir Lerman, artificial intelligence, biomedical research, cardiovascular disease, cardiovascular medicine, COPD, diabetes, education, Florida State University, heart disease, Mayo Clinic Proceedings, medical research education


September 20, 2019 · Leave a Comment

Good news about the effectiveness of antifibrotics for IPF

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]

View full entry Comment on this

Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs


September 13, 2019 · Leave a Comment

REAL WORLD EVIDENCE in health care improvement

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

In late 2012 Optum and Mayo Clinic came together to form OptumLabs, an open, collaborative research and innovation center, dedicated to improving patient care and patient value through data-driven health care research, leading-edge data science and strong partner collaboration.  Since that time, approximately 150 collaborative projects have led to peer-reviewed publication, a critical step towards […]

View full entry Comment on this

Tags: atrial fibrillation, big data, Center for the Science of Health Care Delivery, clinical trials, OptumLabs, research


August 5, 2019 · Leave a Comment

Blood thinners in combination increase bleeding risk, Mayo study finds

By Adam Harringa Adam Harringa (@harringaadam)

Gastrointestinal bleeding is a common side effect for many blood-thinning medications. But new Mayo Clinic research finds that risk is amplified when patients receive more than one blood thinner – especially if they’re 75 or older. The study, published in Clinical Gastroenterology and Hepatology, found patients receiving an anticoagulant drug and an antiplatelet drug, in […]

View full entry Comment on this

Tags: AHRQ, anticoagulant, antiplatelet, blood thinner, Center for the Science of Health Care Delivery, Che Ngufor, gastroenterology, Neena Abraham, Nilay Shah, OptumLabs, Peter Noseworthy, Xiaoxi Yao


April 3, 2019 · Leave a Comment

Research News Roundup-March 2019

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. Removal of ‘zombie cells’ alleviates causes of diabetes in obese mice Mayo Clinic researchers and their collaborators have shown that when senescent […]

View full entry Comment on this

Tags: AFib, aging, Alzheimer's disease, atrial fibrillation, biomarkers, cancer, Center for the Science of Health Care Delivery, clinical trials, diabetes, gastroenterology, hepatitis, JAMA


November 13, 2018 · Leave a Comment

On the Front Lines of Anaphylaxis: Using Data to Save Lives

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

By Ronna Campbell, M.D., Ph.D.;  Megan Motosue, M.D.; and M. Fernanda Bellolio, M.D.; Mayo Clinic Anaphylaxis is a serious, potentially life-threatening allergic reaction that affects millions of Americans. Today, nearly 15 million people in the U.S. have a food allergy and numbers are increasing. Symptoms of anaphylaxis can occur within seconds following exposure to an allergen such […]

View full entry Comment on this

Tags: anaphylaxis, Center for the Science of Health Care Delivery, emergency department, emergency medicine, M. Fernanda Bellolio, Megan Motosue, OptumLabs, Ronna Campbell


September 13, 2018 · Leave a Comment

The rising tide of nonalcoholic fatty liver disease

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

Liver disease? Me? I don’t drink. I don’t smoke. Okay, so I don’t exercise that much, and where did all these candy bar wrappers come from? Anyway, I thought liver disease was just for alcoholics? These are question many Americans ask when diagnosed with nonalcoholic fatty liver disease. But as its name implies, NAFLD is […]

View full entry Comment on this

Tags: Alina Allen, Center for the Science of Health Care Delivery, OptumLabs, Rochester Epidemiology Project


Contact Us · Privacy Policy